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1. Introduction 
The nine months of intrauterine life are a continuum during which a series of situations and 
events can occur that result in abnormalities of normal brain growth or injury to the 
developing brain of the fetus. Genetic mutations and hereditary syndromes can predispose 
the fetus to intrauterine death, mortality in early life, and various degrees and combinations 
of brain injury and neurological deficits. Structural brain injury occurs due to a number of 
well defined and some relatively obscure causes. Premature delivery puts the fetus at risk of 
complications during birth and in the early days of life that can compromise the brain. Such 
infants have systems that are physiologically too immature to function normally, making 
them dependent on a range of care entities many of which are known to have risks 
associated with their use. The end result especially when prematurity is of extreme degree, 
is a significant incidence of cognitive and motor deficits. Maternal infection is increasingly 
recognized to precipitate premature labour and produce inflammatory by-products that 
cross the placenta and increase the vulnerability of the fetus to brain injury. (Gotsch et al, 
2007; Kendall & Peebles 2005; Mercer 2004) Various pathologies related to the placenta also 
compromise the well being of the fetus. Impaired fetal growth secondary to placental 
insufficiency is associated with a reduction in the number of brain cells formed by the time 
the infant is born; growth retarded infants are at increased risk of hypoxic stress and 
hypoxic ischemic brain injury due to failure of placental blood flow, gas exchange and fetal 
oxygen delivery. Suboptimal nutrition also poses the risk of hypoglycaemic brain injury 
immediately after birth. Post mature infants are at risk from placental failure, hypoxic 
ischaemic injury and birth trauma. Infants conceived with in-vitro fertilization are at 
increased risk of neurological disability, especially cerebral palsy. (Stromberg et al 2002) 
Stroke is a significant cause of neurodevelopmental morbidity in newborn infants that can 
result in permanent sequelae and may be underreported. (Ozduman et al 2004) The overall 
incidence of cerebral palsy has not been reduced significantly in spite of advances in 
obstetric care, and CP remains a significant cause for motor deficits and cognitive disability 
that become evident in early life and result in permanent disability.   
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Hypoxia is central to the genesis of a significant proportion of the brain injury that occurs in 
the fetus. Compromised oxygen delivery is a particular risk factor during labour and 
delivery, but the fetus is at risk of brain injury whenever cerebral ischemia occurs as a 
consequence of impaired cerebral blood flow. After hypoxic ischaemic injury, reperfusion of 
the brain and any situations that further compromise normal perfusion, oxygen and carbon 
dioxide transport, or the supply of metabolites required for normal brain function have the 
potential to complicate recovery, and can also contribute to additional brain injury. (Fellman 
& Raivio 1997, von Bell et al 1993) Major mechanisms linked to perinatal brain injury are 
hypoxic ischemic insults and haemorrhagic brain injury in term infants (those born beyond 
37 weeks of gestation) and periventricular haemorrhage and white matter injury 
(leukomalacia) in preterm infants (those born before 37 weeks of gestation). 
Hypoxic ischemic brain injury is estimated to occur in 0.5 – 0.75 per thousand deliveries. The 
pattern and consequences of injury depend on the severity and duration of the insult, the 
neurovascular and anatomical maturity of the brain which is primarily a factor related to the 
gestational age of the fetus, and co-related factors such as the presence or absence of 
infection, problems with fetal nutrition, or pre-existing abnormalities in brain growth and 
development. Ferriero (Ferriero 2004) has reviewed the gestation specific vulnerability of 
different regions of the fetal brain and individual cell lines to damage, and the central role of 
oxidative stress and excitotoxicity in fetal brain injury. 
Infants born very prematurely are at particularly high risk for brain injury as brain 
development in such infants is so immature that they are vulnerable to fluctuations in brain 
blood flow and oxygen delivery that are insufficient to generate injury in a more mature 
fetus. Such fluctuations include variations in cerebral venous pressure, the degree of 
cerebral vasodilatation and constriction, and the distribution of cerebral blood flow, and 
also systemic alterations in circulating blood volume, or oxygen and carbon dioxide tension. 
The periventricular area of the immature preterm brain is particularly prone to injury in 
such ways. Haemorrhage in this area is a major cause of acute brain injury in premature 
infants, and the cystic changes that develop in consequence (periventricular leukomalacia – 
PVL) frequently result in permanent scarring. This form of periventricular haemorrhage can 
also be sufficiently extensive that it extends into the ventricles, where the presence of blood 
within the cerebrospinal fluid is irritant, and as a result often generates ventricular 
dilatation or causes obstructive hydrocephalus. (Volpe 2001a) 
In larger premature infants and those born at term brain injury involving the cortex or basal 
ganglia predominates; (Okereafor et al 2008) watershed damage in the parasagital areas of 
the brain results from moderate hypoxic ischaemic insults, and brain stem injury when 
injury is more profound. (Roland et al 1988) The regionalization of injury is dictated by the 
selective vulnerability of different areas of the brain which depends largely on differences in 
metabolic demand, compensatory mechanisms that occur in response to hypoxia, the 
maintenance of normal levels of substrate delivery (particularly oxygen and glucose), and 
the maturity and type of brain cells undergoing development at the time of injury. 
The immediate clinical effects of hypoxia and ischemia result in an infant who is 
neurologically depressed at birth, requires resuscitation to initiate breathing and sometimes 
cardiovascular support to stimulate heart function and ensure adequate blood pressure and 
circulation. Tone and behaviour are abnormal and an encephalopathy develops in the hours 
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or days after birth where neurological abnormalities include problems with level of 
consciousness, tone, respiratory drive, and coordination of sucking and swallowing, and 
seizure activity usually occurs. In the longer term the consequences of hypoxic ischemic 
brain injury vary between death and complete recovery (Perlman & Shah 2001), with the 
spectrum of long term brain morbidity ranging from mild motor and cognitive defects to 
cerebral palsy and severe cognitive disabilities. 
Importantly many of the causes of fetal brain injury are avoidable and some are amenable to 
treatment. The evolution of hypoxic ischaemic brain injury for example has two phases over 
time. Following the initial insult a ‘latent’ phase follows that is associated with a transient 
recovery of cerebral energy metabolism, then hours or sometimes days later a second phase 
occurs where cerebral energy failure and oedema within the brain cells initially injured 
compounds the degree of injury. (Gunn 2000) The interval between this biphasic response 
offers a therapeutic window during which interventions aimed at ameliorating the effects of 
hypoxia and ischemia are being explored.  
2. Causal mechanisms for structural defects  
Structural development: The structure of the fetal brain evolves throughout intra uterine life. 
Comprehensive reviews describe the initial proliferation of cells, generation of neurons in the 
cortical germinal zone, and process of normal brain growth and maturation. (Hatten 2002; Marin 
& Rubenstein 2003; Larroche et al 1997; Razic 2002) Normal growth involves a continuum that 
must be appreciated in order to fully understand the causes, evolution, and consequences of 
brain deficits associated with abnormalities in fetal brain development. Key influences that 
determine normal structure include genetic, embryonic, nutritional and environmental factors. 
Genetic anomalies are the principal cause of fetal loss. (Heffner 2004) In such circumstances 
brain abnormalities at a macroscopic and microscopic level are commonly evident. Francis 
et al (Francis et al 2006) have reviewed the history and molecular genetic advances in 
cortical development disorders, and use microcephaly to explain the complex mechanisms 
underlying correct development of the human brain. Where a fetus with a genetic anomaly 
is born alive there may or may not be structural brain involvement. While many genetic 
mutations are random most are inherited, although some have variable expression. 
Environmental factors such as radiation or chemical exposure are uncommon but 
preventable causes, and parental age plays an important part. (Heffner 2004) Conception is 
less likely as females and males age, with the proportion of sub-optimal ova and unhealthy 
structurally abnormal sperm increasing exponentially with age, and there is the well 
recognized association between age and a number of genetic syndromes such as Trisomy 21 
(Down syndrome). Infants conceived with the use of assisted reproductive technology are 
more likely than naturally conceived infants to have multiple major defects including 
chromosomal and musculoskeletal defects. (Hansen et al 2002) Some racial groups have a 
predisposition to specific genetic anomalies associated with structural brain abnormalities 
e.g. the Irish and Welsh to neural tube defects and hydrocephalus respectively.  
Genetic counselling is central to diagnosis and prevention in situations where there is a family 
history of genetic abnormality with brain injury, birth of a prior infant with an anomaly, or 
predisposition to a genetic problem due to racial or age related factors. Information from 
autopsy is important after fetal loss, coupled with placental pathology after unexplained 
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stillbirth. An infant born with evidence of brain injury potentially due to a genetic cause 
requires chromosome studies, placental pathology, and family evaluation in addition to 
radiological and general and often specific laboratory studies. Prognosis varies; some genetic 
syndromes are invariably fatal while the spectrum for brain involvement, ability and life 
expectancy is broad in the remainder, hence the need for identifying the chromosomal 
anomaly or specific syndrome and making a definite diagnosis wherever possible. 
Embryonic development progresses at a rapid pace from the moment first cell division 
occurs, and a large proportion of the brain’s structure is already formed by the time many 
women become aware that they are pregnant. By the end of the first trimester (3 months of 
gestation) all the main structures of the central nervous system are formed and it is brain 
growth that follows between this time and fetal maturity (40 weeks). There is always the 
potential for a variety of factors to negatively impact normal embryonic development, and 
in-vitro fertilization (IVF) has known associations with multiple pregnancy, infants of low 
birth weight, and a spectrum of anomalies. (Berg et al 1999, Stromberg et al 2002) 
Nutritional deficiencies can negatively impact brain growth, as exemplified by the key role 
of periconceptual administration of folic acid in the prevention of defective neuropore 
closure. (Hagberg & Mallard 2000) This central role in reproductive health, normal 
neurological system structure, and brain function is underscored by the evolutionary 
adaptation of skin colour in humans to facilitate folate synthesis. When humankind’s 
African ancestors migrated to less sunny climes, a progressive reduction in skin 
pigmentation became essential in order for effective folate (and vitamin D) metabolism to 
occur, as exposure to sunlight and transmission of ultraviolet light through the skin is 
required for the effective production of both folate and vitamin D. (Jablonski 2006). Dietary 
intake is also relevant but optimal folate levels for normal fetal neural development are 
difficult to achieve, especially for sub-populations at particular risk of structural anomalies. 
Hence, for prevention, the majority of pregnant mothers can benefit from folic acid 
supplementation, as evidenced by the fall in neural tube defects in populations where food 
items are now supplemented. Rodent models also provide convincing evidence that iron 
deficiency alters metabolism and neurotransmission in major brain structures, such as the 
basal ganglia and hippocampus, and disrupts myelination brain wide. (Lotzoff & Georgieff 
2006) While evidence for the same issues affecting the human fetus is less clear, even the 
possibility combined with the high worldwide incidence of iron deficiency in pregnancy 
makes iron supplementation logical to reduce the impact of this wholly preventable form of 
brain pathology. 
Environmental factors relevant as a mechanism for brain damage range in severity due to 
the high toxicity of some agents, e.g. cocaine, the effect of dosage and cumulative exposure 
in others such as alcohol, and the frequency of fetal exposure to agents such as nicotine in 
mothers who smoke. Gestational age plays a role principally in that the fetal brain is most 
vulnerable during the early stages of structural development. The impact of environmental 
factors can be multi-factorial with exposure to multiple agents increasing the risk of brain 
damage, and in some situations a genetic predisposition to the toxic effect of individual 
agents is evident e.g. related to alcohol.  
Perhaps the best known association is between fetal exposure to alcohol and the Fetal 
Abnormality Spectrum Disorder (FASD). Heavy prenatal alcohol exposure can have serious 
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and long-lasting effects on the developing fetal brain, that severely affect the physical and 
neurobehavioral development of a child. Autopsy and brain imaging studies indicate 
reductions and abnormalities in overall brain size and shape, specifically in structures such 
as the cerebellum, basal ganglia, and corpus callosum. A wide range of neuropsychological 
deficits have been found in children prenatally exposed to alcohol, including deficits in 
visulospatial functioning, verbal and nonverbal learning, attention, and executive 
functioning. These children also exhibit a variety of behavioural problems that can further 
affect their daily functioning. (Riley & McGee 2005).  
The potential for adverse effects on the fetal brain from maternal drug use is exemplified by 
the effect of cocaine; use of the drug during pregnancy causes structural brain defects; 
increases the incidence of low birth weight with its attendant risks; and multiple functional 
deficits manifest once the child is born, some of which persist as learning difficulty into 
adult life. Sometimes infants exposed to cocaine in utero have ultrasound evidence of cyst 
formation in the frontal lobes of the brain, basal ganglia, posterior fossa, germinal matrix 
and septum pellucidum. These are particularly likely following drug use in the first 
trimester, and probably represent focal necrosis caused by complex vasoconstrictive effects 
of the cocaine. (Dow-Edwards 1991) This vulnerability of the fetal brain to damage in the 
first trimester is not unique to cocaine; many drugs and chemical agents cause structural 
anomalies as this is the time when key structures are being formed. 
Maternal smoking increases the risk of an infant being of low birth weight (LBW) two fold; 
is responsible for 20% to 30% of all LBW infants; and causes such infants to weigh 150-250 g 
less on average than those born to non-smoking mothers. The adverse fetal effects of 
smoking are generated through several pathways. Placental function is impaired by 
vasoconstrictive cigarette smoke metabolites; these can reduce uterine blood flow by up to 
38% depriving the fetus of both oxygen and nutrients. The episodic hypoxia and 
malnutrition that results underlie the intrauterine growth retardation that occurs in many 
infants born to smoking mothers. Nicotine is also a fetal neuroteratogen that targets 
nicotinic acetylcholine receptors in the fetal brain. Changes in cell proliferation and 
differentiation occur, synaptic activity develops abnormally, and cell loss and neuronal 
damage occurs. Even in mothers who do not smoke enough for their infants to be of low 
birth weight, the nicotine levels to which their fetus is exposed are high enough to produce 
deficits in fetal brain development (Law et al 2003) 
Evaluation of structural brain damage: This is a process that combines relevant elements of 
the infant and maternal medical and family history, physical examination findings, and 
laboratory and radiological investigations, including: the infant’s condition at birth 
(requirements for resuscitation, APGAR score, and neurological status); general appearance 
(appropriateness of growth for gestational age, weight, head circumference, and length, and 
presence of associated defects): neurological status (especially tone, cry, ability to feed, and 
seizure activity); fetal sonography and MRI; post-natal ultrasound and neuroradiological 
studies (CT scan MRI); electroencephalogram; chromosome studies; and consultation with 
medical specialists such as a neonatologist, geneticist and neurologist.  
3. Predisposing factors for fetal brain injury 
Prematurity: Brain injury in the premature infant is an extremely important problem, in part 
because of the large absolute number of infants affected yearly. (Volpe 1997) Considerable 
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research documents that children born very prematurely (<32 weeks gestation) and 
or/extremely low birth weight (<1000 g) are at increased risk for neurobehavioral 
impairments (cerebral palsy, blindness, deafness), lower general intelligence, specific 
cognitive defects, learning disabilities, and behavioural and emotional problems. Also that 
the survival rate for extremely preterm infants (<26 weeks gestation or with a birth weight 
of <750 g) is approximately 50% but that 40% of survivors do not escape significant deficits. 
(Anderson & Doyle 2008) Modern neonatal care entities now enable 75-90% of preterm 
infants weighing < 1500g at birth to survive in Europe and the USA; however 5-10% of 
survivors exhibit cerebral palsy and many have cognitive, behavioural, attention-related or 
socialization deficits. (Halopainen & Lauren 2011)  
The two principal brain lesions that underlie the neurological manifestations observed in 
premature infants are periventricular hemorrhagic infarction and periventricular 
leukomalacia. (Volpe 2001a) In the animal model relatively brief periods of hypoxaemic 
compromise appear to be more profound in the less mature brain in mid rather than late 
gestation, when they have significant effects on the fetal brain causing death of susceptible 
neuronal populations (cerebellum, hippocampus, and cortex) and cerebral white matter 
damage. (Rees & Inder 2005) Cerebellar injury is also increasingly recognized 
(Limperopoulos et al 2009)  
Very premature infants are prone to these lesions because the structural anatomy and 
neurovascular immaturity of their brains predisposes them to injury from hypoxia 
(inadequate oxygenation) and ischemia (inadequate blood flow) which predispose them to 
cerebral haemorrhage. The immature brain lacks the duplication of blood supply that 
develops as a fetus matures and the ability to auto-regulate cerebral blood flow in response 
to changes in systemic blood pressure. Areas of the brain such as the germinal matrix have 
vascular complexes that are vulnerable to bleeding when blood pressure fluctuates. Such 
haemorrhage is common related to asphyxial stress and results in a pattern of injury unique 
to the preterm infant. In this context, prematurity is certainly the major causal factor of 
cerebral palsy. However, the literature also indicates that the odds of brain injury become 
much greater in the fetus in the presence of maternal fever, and from the effects of 
inflammation, or proven infection, than when the only risk factor is prematurity. (Rees & 
Inder 2005) 
Premature and low birth weight infants are known to be at increased risk of brain injury as a 
consequence of intrauterine infection when microglial activation triggers excitotoxic, 
inflammatory and oxidative damage, (Malaeb & Dammann 2009) and of developing 
infections during the newborn period. Their postnatal vulnerability is because they are 
compromised in terms of how quickly and how effectively they can mount an immune 
response. This is in large part because bacterial colonization of the gut after birth is essential 
for digestive function, and for production of vitamin K, an essential component of the 
clotting mechanism without which haemorrhagic disease of the newborn can develop. This 
bleeding tendency can involve intracranial bleeds of sufficient severity to cause brain 
damage and even death. As an additional precaution, newborns are routinely given this 
vitamin prophylacticaly after birth. Risk factors for neonatal sepsis include prolonged 
rupture of membranes (beyond 18 hours the risk of infection increases 10 fold, and the 
occurrence of perinatal asphyxia adds additional risk); and maternal colonization with 
group B Streptococcus and urinary tract infection (Gerdes 2004). Prophylactic antibiotics are 
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used in anticipation of sepsis as by the time confirmatory tests (bacterial cultures) are 
positive the risks of increased morbidity or mortality rises. This is due in large part to the 
risk of dissemination of infection e.g. to the brain and meninges causing meningitis, or 
because of the greater levels of toxic metabolites released when the higher counts of bacteria 
present as a consequence of treatment being delayed are killed by therapy. 
Brain injury in premature infants as a consequence of periventricular haemorrhagic 
infarction and periventricular leukomalacia may be preventable. Logical approaches would 
include measures to prevent germinal matrix-intraventricular hemorrhage, prevent or 
manage impairments of cerebrovascular autoregulation and cerebral blood flow, and the 
use of agents such as free radical scavengers to interrupt the cascade to oligodendroglial cell 
death. (Volpe 2001b). Importantly, the consequences of being born prematurely also 
predispose infants born following fetal brain injury to additional compounding stresses and 
insults in the newborn period; such events also pose a threat of increased morbidity and 
long term neurological compromise to those who have intact brains at birth. Hence the high 
overall risk of motor, cognitive, and educational defects in those that survive being born 
prematurely. (Rees & Inder 2005, Anderson & Doyle 2008) 
Low birth weight (LBW) infants are those born weighing <2500 g. LBW infants comprise 
both those born prematurely but appropriately grown for gestational age and those who are 
small because of intrauterine growth retardation. LBW infants accounts for 7.6% of all live 
born infants and 65% of deaths in the United States occur among LBW infants due to 
multiple risk factors related to the underlying cause of their small size. In most instances 
intrapartum morbidity is higher amongst this group, and many are also at risk during the 
newborn period. Brain injury in a fetus of LBW is potentially caused by many factors; where 
placental dysfunction is the underlying cause, acute problems may compromise placental 
gas exchange and precipitate fetal hypoxic ischemic stress.  
Small for gestational age (SGA) infants are those with intrauterine growth retardation who 
when born are below the 10th centile for weight; where length and head circumference are 
also similarly compromised, such infants are known as symmetrically growth retarded and 
brain size and function are usually adversely affected. Long term deficits in neural 
connectivity are described (Rees & Inder 2005) and cognitive problems are common in 
surviving infants. SGA infants have no glycogen stores in their liver at birth and are hence 
prone to hypoglycaemia that can compound pre-existing fetal brain injury. In utero 
maternal blood glucose levels determine fetal levels, and, in addition, the fetal brain is able 
to metabolize lactate as an alternative energy source. However, this pathway is down 
regulated after birth once oral feeding begins. As a group, surviving SGA infants are at 
particular risk in adult life of developing cardiovascular disease, hypertension and stroke.    
Maternal Illness during pregnancy poses a risk for fetal brain injury. Many are specific to 
pregnancy such a pre-eclamptic toxaemia, but others pre-exist prior to pregnancy and of 
themselves, or because of treatment they require, have the potential to cause damage, or 
predispose the fetus to situations such as prematurity or low birth weight that carry 
independent risks for neurological morbidity. Examples that pose clear risks for the fetal 
brain and neurological system are anticonvulsant medications and cancer therapies 
(Halopainen & Lauren 2011). But, while there is general recognition that any medication 
should be considered carefully in the context of pregnancy and wherever possible be 
discontinued, in some instances the wellbeing of the mother has to be weighed against the 
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potential for risk to the fetus. However, not infrequently drugs in common use that are 
initially identified as problematic sometimes only come to be recognized in their true 
context after some years of use and appropriately rigorous research and review.  
A case in point relates to selective serotonin reuptake inhibitor (SSRI) use during pregnancy 
and the effects of these agents on the fetus and newborn infant. Serotonin is a 
neurotransmitter that appears very early in fetal life and has a broad role in brain 
morphogenesis. Studies to evaluate the neurotoxicity of SSRI’s identified a number of age-
specific and site-specific effects in the fetal rat brain, especially related to the limbic system 
(Lattimore et al 2005). Subsequently a number of adverse effects were identified to occur in 
human newborns, and there was a clear association with low birth weight (Oberlander et al 
2006), the need for special care in the newborn period, and an apparent increase in the 
incidence of prematurity (Lattimore et al 2005). This led to calls for SSRI use to be 
reconsidered in pregnancy, although there was debate as to whether the effects observed in 
the newborn were attributable to acute cessation of exposure (withdrawal) or a direct 
prenatal effect. However, this class of medications is widely prescribed to treat a number of 
psychiatric disorders, and is of particular value in severely depressed patients in pregnancy 
(Austin 2006). Hence, following studies of neonatal outcome and meta-analysis of existing 
research, the recommendation now is that the decision whether or not to discontinue SSRI 
use in pregnancy has to be made on a case by case basis. (Oberlander et al 2006; Lattimore et 
al 2005; Austin 2006) 
Another challenge for care givers and concern for pregnant mothers is that the literature 
indicates that something as common as maternal fever during intercurrent illness can pose 
problems. A maternal temperature of 38 0C or higher is an independent risk factor for 
significantly increased fetal  morbidity, and the specific risk of brain damage resulting in 
Cerebral Palsy is increased many fold by maternal fever. (Gotsch et al 2007; Kendall & 
Peebles 2005; Barks & Silverstein 2002; Grether & Nelson 1997)  
Some infections are well known to cause brain injury. Those known collectively as the 
TORCH group (toxoplasmosis, cytomegalovirus and herpes simplex) are examples. 
(Hagberg & Mallard 2000) Some viral infections are associated with stillbirth, and when 
infants are born alive many have systemic effects due to the infectious process. Parvovirus 
B19 infection is an example of an illness that has been associated with severe fetal 
complications; fetal involvement can result in vasculitis that causes pathological changes in 
the central nervous system which can include stroke. (De Haan et al 2006) Fetal outcome 
may be normal but anaemia, hydrops fetalis and stillbirth also occur. Approximately 30–
50% of pregnant women are nonimmune. Fetal infection in the first trimester poses the 
greatest risk. Factor V Leiden mutation can lead to activated protein C resistance which 
increases the risk of thromboembolism, particularly in the presence of dehydration, 
asphyxia and infection. Maternal infections as varied as malaria and syphilis adversely 
affect the fetal brain, and rubella (German measles), varicella (chickenpox) and 
cytomegalovirus, and labour and delivery complicated by chorioamnionitis and FIRS 
(Garite 2001; Wu et al; 2003; Bashiri et al 2006) are associated with an increased risk of 
cerebral palsy and a range of illness specific central nervous system effects. However, upper 
respiratory tract infections and gastroenteritis, which are common and often a concern to 
pregnant women, are not. (O’Callaghan et al 2011). 
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3.1 Fetal inflammatory response syndrome (FIRS) 
Inflammatory mediators are known to precipitate premature rupture of the membranes and 
preterm labour, inflame and cross the placenta, and increase the risk of fetal brain injury and 
cerebral palsy (O’Callaghan et al 2011). Recent literature uses the term Fetal Inflammatory 
Response Syndrome (FIRS). (Khwaja & Volpe 2008; Back & Rivkees 2004; Gotsch et al 2007; 
Bashiri et al 2006; Kendall & Peebles 2005) FIRS is characterized by systemic inflammation, 
activation of the innate fetal immune system, and elevation of fetal plasma cytokines. 
Cytokines are small, peptides or glycoproteins secreted de novo in response to 
inflammation/infection or other immune stimulus. Usually cytokine production is 
responsible for the generation of a normal immune response, but in the immature fetus or 
premature infant born after exposure to FIRS the complex effects of cytokine activity 
significantly increase infant morbidity and mortality, (Gotsch et al 2007; Bashiri et al 2006; 
Barks & Siverstein 2002) because the balance of these agents is imperfectly controlled. 
Cytokines such as Interleukin -1, -3, and -6, and Tumour Necrosis Factor mediate and 
regulate immunity, inflammation, and haematopoiesis (blood cell production), and are 
central to the mechanism for elevation of temperature and stimulation of the bone marrow 
to produce white blood cells in response to infection. (Bashiri et al 2006; Kendall & Peebles 
2005; Barks & Silverstein 2002) Importantly, many cytokines are also vasoactive products 
that increase the vulnerability of the premature fetal brain to hypoxic ischemic injury, and 
substantial evidence indicates that when a fetus is exposed to intramniotic inflammation 
there is an increased risk for direct brain injury that can cause short term morbidity and 
cerebral palsy. (Lee et al 2007) 
In the presence of inflammatory cytokines, focal variations in fetal brain perfusion occur that 
result in local ischemia followed by reperfusion; these perturbations cause cumulative injury 
to the white matter due to the primitive neuro-vascular architecture, immature auto-
regulatory control mechanism, and sensitivity of maturational dependent cells to free 
radical damage in the immature brain (Volpe 2001b) The germinal matrix is particularly 
vulnerable to variations in brain blood flow and blood pressure; consequently, 
periventricular hemorrhage is all the more likely to occur in the preterm fetus exposed to 
FIRS; such haemorrhage may extend into the ventricular system to cause intraventricular 
hemorrhage. The literature emphasizes “the synergistic role of inflammation and hypoxia 
and ischemia when they occur together”, and the higher incidence of hypoxic ischemic brain 
damage that results in a fetus exposed to maternal inflammation/infection. 
The literature also supports a role for inflammatory mediators in the mechanisms of preterm 
premature rupture of membranes (PPROM), premature labour and delivery, and links 
“maternal infection and pro-inflammatory mediators in the neonatal systemic circulation 
with an increased risk of PVL and/or spastic diplegia.” (Back 2004; Bashiri et al 2006;  Barks 
& Silverstein 2002, Lee et al 2007; Grether 1997; Mercer 2004; Asrat 2001) Maternal cytokines 
are able to cross the placenta, enter the fetal circulation, cross the brain blood-brain barrier, 
and produce an inflammatory response in the white matter of the fetal brain which leads to 
brain damage. (Malaeb & Dammann 2009) Also, the incidence of fetal distress (Kilbride & 
Thibeault 2001) and hypoxic insults (Garite 2001) is higher following PPROM than in 
pregnancies with preterm labor and intact membranes. This is largely because of the 
increased risk of cord compression (Garite 2001; Mercer 2004; Kilbride & Thibeault 2001; 
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Ehrenberg & Mercer 2001) due to low amniotic fluid (oligohydramnios) as a consequence of 
membrane rupture, although chorioamnionitis and placental dysfunction may also be 
contributory. FIRS has been observed in fetuses with preterm labour with intact membranes, 
preterm prelabour rupture of the membranes, where there is proven fetal viral infection, 
and also where no microbial invasion is proven. In addition, cytokine release occurs in the 
fetus following contamination in the birth canal after membrane rupture. Inflammatory 
products entering the fetal lung then pass into the blood stream and generate an 
inflammatory response and systemic cytokine release in the fetus.  
FIRS has been proved in a series of research studies to be a risk factor for short term 
perinatal morbidity after adjustment for gestational age at delivery, and also for 
development of long term sequelae, including brain damage (Gotsch et al 2007) 
“Intrauterine infection/inflammation is one of the most common causes of neonatal 
complications including preterm delivery, and considered to be the leading identifiable risk 
factor for cerebral palsy.” (Bashiri et al 2006) Epidemiological evidence suggests that 
exposure to a combination of infection and hypoxic-ischaemic insult dramatically increases 
the risk of developing cerebral palsy compared with either insult alone. (Kendall & Peebles 
2005) Cytokine mediated brain damage is known to occur as a direct result of an 
inflammatory process.  
In addition to direct cytokine mediated brain damage circulating cytokines also compound 
the effects of any hypoxic ischemic stress experienced by the fetus. Consequently the 
severity of any resultant hypoxic ischemic brain damage is increased, particularly in the 
premature brain. (Gotsch et al 2006; Kendall & Peebles 2005) Thus causal mechanisms for 
the higher incidence of periventricular leukomalacia in a preterm fetus with FIRS include:  
 maturation-dependent factors that render the premature infant’s brain exquisitely 
sensitive to the occurrence of white matter injury;  
 fetal distress being more common following PPROM (intrapartum fetal heart 
decelerations are seen in over 75% of patients);  
 the higher incidence of hypoxic ischemic brain damage occurring in affected fetuses; 
 reduction by cytokines of the threshold at which hypoxia becomes neurotoxic; 
 the synergistic effect of inflammation with hypoxia and ischemia when they occur 
together;  
In the context of limiting brain injury, management of cases of FIRS requires consideration 
of the maturity of the fetus and a balance of the risks of treating the mother and expediting 
delivery. “Fetal microbial invasion that results in a systemic fetal inflammatory response 
can, in the absence of timely delivery, progress to cause organ dysfunction, shock and 
perhaps death.” (Gotsch et al 2007) However, the risks of brain injury associated with being 
born prematurely have to be weighed against those that exist from  remaining in utero. In 
practice specialists in obstetric and newborn care must together evaluate the relative risks 
and act accordingly. The incidence of infection seems greatest in the first 72 hours following 
PPROM. (Kilbride & Thibeault 2001)  Immediate induction of labor, compared with 
expectant management, results in lower rates of chorioamnionitis, fewer babies requiring 
admission to neonatal ICU, and fewer requiring treatment with antibiotics for suspected 
sepsis with this approach. The literature states: “For the premature fetus, once clinical 
chorioamnionitis occurs, rates of sepsis, pneumonia, respiratory distress syndrome and 
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death are all increased by 2-4 fold and long-term neurologic injury is substantially more 
likely to occur.”(Asrat 2001) There appears to be no role of expectant management in any 
patient with PPROM beyond 34 weeks gestation; (Canavan et al 2004) and: At 34-36 weeks 
gestation, the risk of severe neonatal morbidity and mortality with expeditious delivery is 
low. Conversely, conservative management is associated with an 8 fold risk of amnionitis; 
hence these women are best served by expeditious delivery with labour induction. (Mercer 
2004) Even at 32 weeks of gestation, premature infants can be expected to have a 92% intact 
survival; it is when pregnancy is less advanced that the pros and cons of initiating delivery 
discussed in the literature have to be considered. The literature also indicates strategies that 
can be used to down-regulate the inflammatory response and treat mothers who have the 
signs and symptoms suggestive of infection. Some antibiotic therapies will reduce cytokine 
production; (Gotsch et al 2007; Kilbride & Thibeault 2001) also, because of the independent 
association of elevated maternal temperature with worse fetal outcome, appropriate 
management and control of fever is also cited as a treatment of potential benefit. (Gotsch et 
al 2007; Kendall & Peebles 2005) 
3.2 Hypoxia 
As the physiologist Haldane said: “Hypoxia not only stops the machine it wrecks the 
machinery.” (Haldane 1922) A healthy fetus can respond to, and tolerate, the early effects of 
hypoxia and the degree of acidosis that occurs initially in response to the associated 
retention of carbon dioxide. In addition, once significantly stressed, the fetus has the 
physiologic ability to preferentially perfuse the deep structures of the brain with the highest 
metabolic rate when systemic acidosis becomes more severe. However, this compensation 
ultimately fails if the ongoing hypoxia remains unrecognized and unrelieved over the 
course of an hour or more, and the end result is extensive grey matter damage. In addition 
to this partial and prolonged pattern of hypoxic ischaemic injury, situations occur where the 
event is more acute and profound in nature. With such insults, acidosis develops relatively 
abruptly, little or no compensatory redistribution of blood to the deep structures of the brain 
occurs, and brain injury happens over a much shorter time frame.  
Distinction between these two patterns is important from a preventive, diagnostic and 
prognostic standpoint and over issues of causation in a medico-legal context. Modern 
neuroimaging (CT and MRI) is the definitive way to distinguish between them based on the 
selective patterns of brain damage caused. Following partial and prolonged 
hypoxia/ischemia, the compensatory redistribution of blood results in the brain’s cortical 
areas being less well perfused and hence the predominant regions damaged, and there is 
also associated hypoxic ischemic injury of multiple organs other than the brain. Where the 
insult is acute, near total (or profound) in nature, the deep structures of brain (thalami and 
basal ganglia) are predominantly damaged because there is no time for effective 
redistribution of cerebral blood flow to maintain their perfusion. (Roland et al 1998; Cowan 
et al 2003) Basal ganglia injury often predominates (Logitharajah et al 2009) and is most 
common in infants with acidemia and HIE. (Ruis et al 2009) Brainstem injury can be 
associated with severe basal ganglia, white matter and cortical injury, (Logitharajah et al 
2009) and non survival. (Roland et al 1988) Secondary multi-organ injury may still occur to 
some degree but is usually mild or absent.  
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A recent review identified 5 sub-patterns of acute near total injury. (Okereafor et al 2008) In 
pattern 1, basal ganglia and thalami lesions were associated with severe white matter 
damage; pattern 2 had basal ganglia and thalami lesions with mild or moderate white 
matter changes; pattern 3 had isolated thalamic injury; pattern 4 moderate white matter 
damage only; and pattern 5 mild white matter lesions or normal findings. In 93% of infants 
with patterns 1 and 2 the internal capsule was abnormal - 86% of them died or developed 
cerebral palsy. Infants with patterns 3 and 4 developed developmental delay and diplegic 
cerebral palsy respectively. Those with pattern 5 had normal outcomes. Case infants were 
significantly more likely of African descent, born to pluriparous or hypertensive mothers, or 
involve uterine rupture following previous caesarean section or undiagnosed breech 
presentation accompanied by prolapse of the umbilical cord.  
The time line of acute near-total hypoxic ischemic events can be extrapolated from data 
obtained in animal studies.  In these studies, monkeys exposed to complete, i.e. total 
hypoxia and ischemia (generated experimentally by ligating the umbilical cord and 
preventing any respiration), could tolerate 10 minutes of hypoxic ischemic insult without 
permanent effects if they were delivered/resuscitated immediately after this time.  Where 
the hypoxic ischemic event was allowed to continue beyond this period for an additional 10 
minutes a cumulative increase in the level of neurological damage was then evident.  Where 
the event extended beyond 20 minute, the fetal monkeys died, in spite of 
delivery/resuscitation.  
In applying this data to the human fetus, it is recognized that what occurs most often is a 
near total (profound) interruption of brain blood flow and oxygen delivery, rather than an 
event where hypoxia and ischemia are absolutely total in nature. Hence the time-line for 
tolerance of such events, and the period over which brain damage evolves, are accepted as 
being longer than in the landmark animal studies conducted by Meyers. (Meyers 1973; 
Meyers 1975a; Meyers 1975b; Ginsberg & Meyers 1974) For this reason, it is generally agreed 
that approximately 15 minutes, and possibly up to 20 minutes, of sudden profound 
asphyxia can be tolerated by the human fetus prior to brain damage beginning (in contrast 
to the ten minutes seen in the animal model). Then, after this ‘grace’ period, damage to the 
brain begins to occur and over a further period of 15 to 20 minutes the extent and severity of 
injury becomes progressively more profound over time. And beyond this period, a human 
fetus is usually born dead. It is also important to recognize that the principal mechanism 
that causes asphyxial brain injury in the fetus is cerebral ischemia caused by the severe 
reduction in cerebral blood flow that occurs as a result of hypoxic myocardial depression 
significantly reducing cardiac output. The fetal heart has a fixed stroke volume, which 
means that cardiac output and the amount of blood supplied to the brain is determined by 
the rate of heart contraction. With hypoxia and acidosis, myocardial depression leads to a 
reduction in heart rate; and significant slowing of the fetal heart (bradycardia) equates with 
a proportional reduction in cardiac output and reduction in cerebral blood flow.  
The relationships between the pattern and time course of an asphyxial insult with the site of 
brain injury and type of disability that results have been summarized by Robertson and 
Perlman (Robertson and Perlman 2006). Acute, near-total insults of moderate degree with 
injury to the basal ganglia and thalami result predominantly in athetoid or dystonic cerebral 
palsy with intact or mildly impaired cognitive development. When severe and prolonged 
acute insults damage the cerebral cortex in addition to deep brain structures severe spastic 
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quadriplegia results, with associated cortical visual impairment, microcephaly and 
significant cognitive deficits. Prolonged partial insults of moderate degree with injury to 
watershed regions result in moderate spastic quadriplegia with variable cognitive deficit, 
but when severe, with extensive cortical brain involvement, result in spastic quadriplegia, 
severe cognitive impairment, cortical visual impairment, and microcephaly.  
Periventricular leukomalacia (PVL) Is predominately, but not exclusively, a condition 
affecting the preterm infant.  PVL can develop during fetal life and in the newborn period. 
The primary mechanism is hypoxic ischemic injury, and the ischemic component (period of 
inadequate blood flow) is generally regarded as the major mechanism of injury.  
Neurobiologic research has shown that maturational dependent oligodendroglial precursor 
cells are a major target in PVL, and exquisitely vulnerable to damage by free radicals 
generated during ischemia/reperfusion. (Volpe 2001b) The premature infant has an 
immature pattern of brain blood supply and a reduced ability to control brain blood flow. 
(Khwaja & Volpe 2008; Back & Rivkees 2004)   PVL develops after periods of abnormally low 
blood flow in the cerebral white matter in areas where there are arterial end zones and 
border zones present, due to the immaturity of a preterm infant’s neurovascular 
development. Autoregulation of cerebral blood flow is also often impaired in such infants; 
and where systemic hypotension occurs or there are episodes of fluctuant or inadequate 
cerebral blood flow for any reason, hypoxic ischemic brain damage can occur involving the 
vulnerable periventricular areas. (Volpe 2001a). Where a mother has prolonged premature 
rupture of the membranes (PPROM), her fetus is recognized to have an increased risk for a 
number of complications that can cause brain damage. Although not every fetus is affected 
directly or indirectly by the inflammatory cytokines generated under such circumstances, 
where such brain damage does occur this often manifests as PVL (Back & Rivkees 2004; 
Gotsch et al 2007)  
PVL is associated with Intraventricular haemorrhage (IVH) in approximately 25% of cases; 
the pathogenesis of IVH is usually multifactorial. See Table 1. 
 
 Fluctuating cerebral blood flow  
 Increased cerebral blood flow 
 Increased cerebral venous pressure 
 Decreased cerebral blood flow followed by reperfusion 
 Disorders of coagulation, platelet function and capillary integrity 
 Vulnerability to hypoxic ischaemic injury 
Table 1. The major pathogenic factors for IVH (Modified from Volpe 2001a) 
Infants with PVL secondary to significant intrapartum hypoxic ischaemic injury will usually 
be abnormal on neurological exam at birth; PVL acquired intrapartum may manifest as 
lower limb weakness evident in the first weeks of life. (Volpe 2001a) PVL can be aggravated 
by or generated due to postnatal events. The commonest clinical situation in which the most 
important pathogenic factors combine to generate sufficient ischemia to cause PVL is when 
a sick preterm infant requires mechanical ventilation; i.e. vascular anatomic factors, 
physiologic factors, the pressure passive nature of the immature cerebral circulation, 
systemic variations in blood pressure, and the effects of hypocarbia (Khwaja & Volpe 2008; 
Volpe 2001a). If infection is the cause for assisted ventilation being required or if morbidity 
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from a prior infection is superimposed, the probability of ischemia and/or haemorrhage 
compromising the periventricular vasculature is much greater. 
Many infants born with PVL have a normal neurologic outcome. Those who have brain 
injury sufficient to generate permanent sequelae exhibit a range of problems that manifest 
with varying degrees of severity; including intellectual and visual deficits that are usually 
superimposed on spastic paresis involving the extremities where the lower limbs are 
predominantly affected. 
Hypoxic ischaemic encephalopathy (HIE) is “an acute non-static encephalopathy caused by 
intrapartum or late antepartum brain hypoxia and ischemia”; (Robertson & Perlman 2006) 
this clinical state evolves during the first days of life following significant hypoxic ischaemic 
insult, and is a major predictor of neurodevelopmental disability.(Ferriero 2004) Prospective 
studies incorporating MRI suggest that the majority of cases of encephalopathy occur as a 
result of brain injury that occurs at or near the time of birth. (Cowan et al 2003) After a 
severe insult depression of consciousness is common in the first hours, hypotonia and 
reduced movement occur, particularly with cortical injury, and the onset of seizure activity 
is common.  
The probability that hypoxic ischaemic brain injury will result in permanent neurological 
consequences is recognized to increase with the severity and duration of HIE. The 
distinguishing features of three clinical stages  of HIE  (mild, moderate and severe) were 
classified by Sarnat and Sarnat (Sarnat and Sarnat 1976) based on observations in 26 full 
term newborn infants exposed to perinatal asphyxia. See Table 2. 
Infants who develop HIE exhibit a range of alterations in conscious level and behaviour 
from a hyper-alert state through irritability to lethargy and obtundation. Disorders of tone 
are also evident that again range from an increase through to a  marked decrease. And a 
variety of abnormal movements occur from tremors and jitteriness  through to frank 
seizures. Other clinical manifestations include apnoea (temporary cessation of breathing) 
with bradycardia and impaired oxygen saturation, shrill cry, feeding difficulty (mainly 
due to poor coordination of suck, but occasionally due to brain stem damage), 
exaggeration of the Moro and deep tendon reflexes, and decerebrate or decorticate 
posturing. The severity of HIE symptoms depends on the timing and duration of the 
causal insult. (Rees & Inder 2005) Each infant’s clinical state evolves following the hypoxic 
episode, often with marked changes evident initially over the course of hours, and then 
later over days or weeks, necessitating serial examination and evaluation with EEG and 
neuroimaging.  
An encephalopathic state develops after 1-6 per 1000 live births. Mortality is high (15-20% in 
some series) with most deaths occurring within a month of injury due to associated multiple 
organ failure or termination of care. In about 25% of cases  permanent neurologic deficits 
remain. Not all cases of neonatal encephalopathy are due to anoxia or hypoxic ischaemic 
injury; (Ferriero 2004; Volpe 2001a) but epidemiological studies confirm the association of 
HIE with pregnancy related risks (maternal pre-eclamptic toxaemia, hypertension, FIRS, and 
infertility treatment) and a range of intrapartum risk factors that predispose the fetus to 
hypoxic ischaemic brain injury. Postnatal aggravation of intrapartum acquired injury occurs 
relatively rarely (10%), but is a preventable component in many instances. Prevention 
centres on anticipating and limiting the adverse effects on the brain of fluctuations in 
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cerebral perfusion, respiratory distress, sepsis, metabolic instability, and any situation that 
increases oxygen and energy demands (e.g. as occur with protracted seizures).   
 
STAGE   CLINICAL FEATURES EEG DURATION AND 
OUTCOME 
1 - Mild 
 State - Hyper-alert, 
irritable, jittery      
 Tone - normal                    
 Suck – weak 
 Seizure - none          
 normal (awake)    
 lasts < 24-48 
hours     
 < 1% have poor 
outcome 
2 - Moderate     
 State - Lethargic, 
obtunded  
 Tone - mild  hypotonia    
 Suck – weak or absent      
 Seizures  - common: 
variable  (focal or 
multifocal)    
 Early – low 
voltage  
 Later - periodic 
discharges, focal 
spike and wave 
 lasts days        
 20 - 40% poor 
outcome  
3  - Severe 
 State - 
Stuporous/Comatose 
 Tone - flaccid 
 Suck - absent 
 Seizures – decerebrate 
posturing 
 Early – periodic 
pattern 
 Later -  
isopotential 
 lasts days to 
weeks    
 100% poor 
outcome 
Table 2. The Sarnat Score (modified from Sarnat and Sarnat (Sarnat & Sarnat 1976)) 
Seizures: major causes of seizures include brain malformation, structural injury, or 
reversible metabolic disorders. The clinical signs vary from subtle movement disorders to 
focal or generalized brief or sustained convulsive activity. Abnormal movement often 
involves the eyes (blink, staring, horizontal tonic deviation), mouth (lip smacking or 
sucking, tongue thrusting), extremities (bicycling/rowing or jerking), or respiratory 
muscles (apnoea). Variations in heart rate occur (tachycardia and bradycardia), often with 
colour change due to a degree of oxygen desaturation. Focal clonic seizures may imply 
brain damage due to arterial or venous infarction. The suspicion that clinical signs 
represent seizures should be confirmed by electroencephalogram (EEG). MRI can help 
distinguish between seizures due to hypoxic–ischemic events and those caused by other 
forms of metabolic or genetic disease, (Huang & Castillo 2008; Alkalay 2005; Alkalay et al 
2005a; Alkalay et al 2005b; Barkovich et al 1998; Efron et al 2003) and provides 
information on the extent of traumatic and infectious causes. Preventable/reversible 
causes of seizures include hypoglycemia, hypocalcemia, hyponatraemia, hypoxemia, and 
acidosis. However delayed treatment probably increases the risk of residual 
consequences; and considerable stresses are placed on the brain by the high oxygen and 
substrate requirements implicit when seizures are prolonged. (Tasker 2001) However, 
seizures do not always imply poor neurodevelopmental outcome for affected newborns.  
The number of term infants who survive HIE is lower than those who are extremely 
premature, but the proportion who survive with long term sequelae is higher; such infants 
require follow up and management of their handicaps: regimens to do this have been 
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described. (Robertson & Perlman 2006) Outcome prediction for infants with HIE has been 
proposed using defined periods (0-6 hours after birth, 6-72 hours after birth, and before 
discharge) and clinical, imaging and electrophysiological predictors, and neurological 
examination criteria. The purpose is to rationalize hypothermia and other intervention 
therapies, including the withdrawal of support, and improve knowledge related to the 
continuum that HIE and the evolution of the brain injury that underlies its pathology 
represents. (Perlman & Shah 2011). 
Entities aimed at minimizing the effects of HIE are evolving. Controlled reoxygenation to 
avoid hyperoxia is one. Drugs with potential as therapies include novel anti-oxidative 
agents such as N-acetylcysteine, neuroprotective agents targeted at glutamate receptors and 
others such as magnesium sulphate, endocannabinoids; (Halopainen & Lauren 2011; Todd 
et al 2011) and controlled hypothermia shows promise. (Vannucci & Perlman 1997; Gunn & 
Gluckman 2007; Ferriero 2004; Schulzke et al 2007; Higgins et al 2006). The concept for 
cooling being beneficial during recovery from encephalopathy stems from animal studies 
and the neuroprotective effect of hypothermia in cases of near-drowning in children and 
during cardiac surgery involving periods of cardiac arrest. Early studies using short periods 
of cooling in encephalopathic newborns had limited and contradictory results; recent 
experimental studies are more promising having shown that moderate cerebral 
hypothermia initiated as soon as possible after the initial insult, before the onset of 
secondary energy failure, and continued for 48 hours or more is associated with 
neuroprotection (Gunn & Gluckman 2007) Randomized clinical trials that used either 
systemic cooling or selective head cooling in encephalopathic neonates also suggest 
moderate hypothermia is safe, (Gunn & Gluckman 2007; Feigin et al 2004) and that 
newborns with moderate encephalopathy are better from a neurodevelopmental perspective 
than normothermic controls at the same age in early infancy. (Gunn & Gluckman 2007) 
However, a 2005 working group (Higgins et al 2006) while seeing this as a “potentially 
promising therapy”, identified significant unresolved issues; central to these is how to 
identify which babies are most likely to benefit (Gunn & Gluckman 2007) and the relative 
safety and benefit of different techniques of cooling. (Gunn & Gluckman 2007; Schulzke et al 
2007). Hence studies are ongoing, as with any experimental therapy, the potential for good 
results must be balanced against any adverse systemic effects and long term follow up data 
obtained.  
One element that would aid in this process and documenting the severity and evolution of 
brain injury is novel monitoring techniques that allow oxygen supply and demand and 
cerebral haemodynamics to be evaluated. An example of a technology that has been tried in 
this regard and continues to show potential is near infrared (NIR) spectroscopy (NIRS). 
NIRS is an established non-invasive optical technology using energy from the NIR spectrum 
to monitor changes in local blood flow and hemodynamics non-invasively within the 
microcirculation, and detect differences in tissue oxygen delivery, consumption and 
utilization. NIRS has been used to study healthy and injured brain (Wyatt 1993; Chen et al 
2002; Sakatani et al 1998; Lin et al 2009), and is a promising tool for determining optimal 
cerebral perfusion pressure for patients with acute brain injury (Brady et al 2007). 
Comprehensive reviews describe the basic principles, limitations and parameters that can be 
quantified. (Ferrari et al 1992; Wolf et al 2007; Ferrari et al 2004; Rolfe 2002; Macnab 2009). 
NIR spectroscopy uses energy from the NIR spectrum to follow variations in the 
www.intechopen.com
 
The Etiology and Evolution of Fetal Brain Injury 
 
17 
concentration of oxygenated (O2Hb) and deoxygenated (HHB) haemoglobin, and employs 
many of the fundamental principles of physics relating to the transmission of light through 
tissue. However, it is the unique combination of the transparency of tissue to NIR 
wavelengths and the specific absorption spectra of oxygenated and deoxygenated 
haemoglobin that form the basis of biomedical applications of NIR spectroscopy. Reviews 
describe the development of instrumentation, the technical specifications of individual units 
and recent advances in the technology. (Ferrari et al 1992; Wolf et al 2007; Ferrari et al 2004; 
Rolfe 2002; Macnab 2009; Yodh & Boas 2003;  Hoshi 2007) Because the initial concentration 
of O2Hb and HHb in the tissue being monitored is unknown, only absolute changes in 
concentration relative to the initial baseline concentration can be derived using conventional 
NIR spectroscopy.  However, with real time sampling and graphic conversion of data, the 
patterns and magnitude of change derived provide valuable information, as they can be 
used to infer physiologic change occurring within the tissue interrogated. (Hamaoka et al 
2007; Ferrari et al 2011; Wolf et al 2007) Examples of such changes include:  
 an increase or decrease in O2Hb (an indirect measure of oxygen content);  
 an increase or decrease in the total haemoglobin - tHb [O2Hb + HHb] (change in blood 
volume);  
 an abrupt decrease in O2Hb with simultaneous increase in HHb (ischemia); and  
 a gradual decrease in O2Hb and increase in HHb (hypoxia).  
The absolute ratio of O2Hb to tHb can be determined using spatially resolved spectroscopy 
(SRS), (Murkin & Arango 2009; Suzuki et al 1999) which requires an instrument to have 
either a multiple segment photodiode chip or an array that has multiple emitter-detector 
distances. Such pathlength geometry allows light detection at two or more different 
distances from the emitter, which enables the absolute ratio of O2Hb to tHb to be 
determined, and a calculation of tissue oxygen saturation to be made. On instruments with 
SRS capability this parameter is variously referred to as the ‘tissue oxygenation index’ (TOI), 
‘tissue saturation index’ (TSI %), or ‘mean tissue Hb saturation’ (rSO2). (Shadgan et al 2009; 
Owen-Reece et al 1999; Tobias 2006) 
NIR spectroscopy is an attractive technology for clinical monitoring because it is non-invasive, 
uses a non-toxic energy source, and can monitor physiologic change continuously with high 
temporal resolution. (Ferrari et al 2004; Rolfe 2000) Investigators value the ability to make 
comparison between sites of measurement using multichannel instruments, and conduct 
studies in real time. Monitoring in real time in situations where being able to identify the onset 
of adverse events allows potentially remediable intervention is attractive clinically, 
particularly where the brain or spinal cord are affected (e.g. by the onset of ischemia). (Murkin 
& Arango 2009; Macnab et al 2002, Macnab et al 2003) In brain studies NIRS has yielded 
“much credible and some important clinical research data,” (Simonson & Piantadosi 1996) and 
a threshold for cerebral ischemia has been defined using SRS.  (Al-Rawi 2005) 
Early studies in newborn infants showed that changes in cerebral blood flow and blood 
volume occurred in the hours following hypoxic ischemic brain injury. (Wyatt 1993; von Bel 
1993; Fellman & Raivio 1997) Stresses that most sick premature newborn infants experience, 
including painful stimuli and loud noise, also affect cerebral haemodynamics, (Gagnon et al 
1999) and over time such disturbances have been suggested as a mechanism that might 
explain the neurological morbidity evident in many infants who do not have specific illness 
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or adverse events to which to attribute their motor or cognitive problems. Auditory evoked 
changes in cerebral oxygenation are evident after hypoxic ischemic injury (Chen et al 2002). 
Animal studies have quantified the effects of graded hypotension on cerebral blood flow, 
blood volume and transit time; (Ferrari et al 1992) and with continuous time domain 
analysis cerebral oximetry have allowed assessment of autoregulation, which could be used 
as a means of optimizing cerebral perfusion pressure in patients with acute brain injury 
(Brady et al 2007). Most recently mapping of cortical blood flow using grids of NIRS sensors 
has identified cortical areas responsible for speech and language development.  
Future advances in hardware and software related to MRI, spectroscopy and diffusion 
tensor imaging will likely allow such technologies to contribute more by delineating the 
site(s) and extent of neuronal injury, (Perlman 2011) and aid in evaluation and management 
strategies able to mitigate the long term effects of perinatal brain injury. 
Multisystem involvement: The consequences of fetal hypoxic ischemic stress extend 
beyond the brain. The lungs of asphyxiated infants can be injured directly by hypoxia, as a 
consequence of inhaled meconium, secondary to left ventricular failure, or compromised 
from pulmonary hypertension. (Lapointe & Barrington 2011) The end result is impaired gas 
exchange and the need for assisted ventilation to maintain adequate oxygenation and 
carbon dioxide exchange. The risks of brain injury increase where such effects are 
superimposed on the poorly compliant lungs of a preterm infant; pneumothorax (air leak 
into the pleural space causing lung compression) is less common with modern ventilation 
techniques, but when it occurs, major disturbances in cerebral perfusion pressure result that 
increase the risk of serious brain haemorrhage.  
Direct damage is caused to the myocardium of the heart; this and the consequences of 
compensatory mechanisms to preserve cerebral perfusion that divert blood flow away from 
other organs result in a recognizable clinical and laboratory picture; as summarized in the 
Table by Phelan in a recent study with definitions based on Hankins et al. (Phelan et al 2011; 
Hankins et al 2002) The cardiac effects of myocardial ischemia compromise conduction and 
mechanical (contractile) efficiency, and often require heart function  to be supported with 
inotropic agents such as dopamine to maintain adequate circulation. Functional and 
conduction abnormalities are evident on cardiac echo and electrocardiogram, and elevated 
cardiac enzymes reflect heart muscle damage. The other multisystem effects are principally 
on renal, hepatic, and bone marrow function. Renal injury is the best systemic marker of 
potential brain injury; especially when reduced urine output (oliguria = urine output 
<1ml/kg/h) is associated with an abnormal neurological examination. (Perlman 2011) 
Absent or significantly reduced urine output in the 24 hours following hypoxic ischaemic 
injury is common, is often accompanied by haematuria, and reflects renal tubular damage. 
Blood urea and serum creatinine concentrations rise progressively and peak in the days 
following injury. Inappropriate secretion of antidiuretc hormone occurs, which causes fluid 
retention, which causes serum sodium levels to fall (hyponatraemia). The effect on the bone 
marrow and haemopoesis is reflected by an increase in the release of nucleated red blood 
cells which peaks at 6-8 hours after brain injury and falls to normal by 36-72 hours. Platelet 
numbers fall (thrombocytopaenia), sometimes by 12 hours, the nadir occurring at 2-3 days. 
(Beyene et al 2009) Thrombocytopaenia can be severe enough to cause or potentiate bleeding 
including within the brain. Serum calcium levels often fall; liver enzymes reflecting hepatic 
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cellular damage increase, and blood glucose concentration can fluctuate, with low levels 
(hypoglycaemia) being most common.  
Hypoglycaemia has recognized neurologic consequences, (Alkalay et al 2005a; Burns et al 
2008; Karimzadeh et al 2011) especially when low glucose concentrations cause or 
accompany seizures. E.g. motor and/or psychodevelopmental delay, microcephaly (Alkalay 
et al 2005b), spastic quadriplegia and hemiplegia, seizures and visual impairment (Burns et 
al 2008). Imaging studies document the presence of oedema and hyperechogenic areas in the 
acute phase (Alkalay et al 2005b), and later, a high incidence of white matter injury, 
including a proportion with global damage (Burns et al 2008). Focal damage evident 
unilaterally or bilaterally has also been seen in a range of locations, including in the parietal 
and occipital lobes, and cortex, and in one case in the brain stem (Alkalay et al 2005a; Burns 
et al 2008; Barkovich et al 1998). Hyperglycaemia also has the potential to cause or aggravate 
brain damage, principally because of the hyperosmolar state that ensues (Efron et al 2003; 
Volpe 2001a). 
 
Organ Involved  Clinical / Laboratory Features 
Heart 
Cardiac dysfunction requiring dopamine to support circulation 
Elevated creatine phosphokinase (CPK)  
Echocardiogram/electrocardiogram abnormalities 
Kidneys 
Absent or reduced urine output  
Elevated creatinine  
Liver 
Global hepatic dysfunction with elevated enzymes  
 serum glutamic-oxaloacetic transaminase (SGOT)  
 serum glutamic-pyruvic transaminase (SGPT)  
 lactate dehydrogenase  (LDH)  
Lung 
Abnormal respiratory drive and lung compliance requiring assisted 
ventilation  
Intestines 
Feeding intolerance 
Abnormal peristalsis   
Bone Marrow 
Release of primitive cell lines (nucleated red blood cells) 
Depression of total platelet numbers  
Table 3. Multisystem Involvement in the first days of life following fetal hypoxic  
ischaemic injury (Modified from Phelan et al 2011) 
Prevention of hypoxic ischaemic brain injury centres on labour and delivery but relies on 
attention to multiple factors during many phases of pregnancy. Good antenatal care is 
fundamental to optimal maternal and fetal health. Prior medical history, particularly 
pregnancy outcome, needs to be considered; then regular maternal examination and 
investigation follow to confirm gestational age, ensure appropriate fetal growth, and plan 
for appropriate timing and means of delivery; supervision during labour provides the 
means for anticipation, monitoring and intervention that underlie good obstetric care and 
underpin optimal fetal outcome including the lowest chance of brain injury occurring for 
any reason.  
In the context of intrapartum situations that put the fetus at risk of neurological sequelae, 
guidelines exist for most situations to anticipate, prevent, or minimize morbidity. In many 
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situations, and with fetal hypoxia in particular, the physiological effects on the fetus 
generate detectable changes in the fetal heart rate. The fetal myocardium and brain are 
sensitive to reduction in oxygen tension, and become all the more so as elevation of carbon 
dioxide occurs and significant acidosis develops. Importantly, the changes in heart rate and 
cardiac function that result occur prior to brain metabolism being affected sufficiently for 
damage to begin. A non-reassuring pattern or individual changes in fetal heart rate 
reflecting alteration in cardiac function occur, most often in relation to uterine contractions 
which even during uncomplicated labour place an element of stress of the fetus. This is 
because the haemodynamics of placental blood flow alter as the tone of the uterus increases; 
blood flow through the umbilical cord on which the fetus depends is also vulnerable during 
contractions. During the later stages of labour, when the fetus is moving down the birth 
canal, cord compression, entrapment or prolapse through the cervix can occur. These 
situations compromise blood flow to varying degrees; in addition to oxygen delivery to the 
fetus being affected, perfusion and removal of carbon dioxide and acids from the fetus can 
become impaired. Sometimes a ‘sentinel event’ is detected with an abrupt and sustained 
drop in fetal heart rate. Such events occur in association with events such as uterine rupture, 
placental abruption, cord occlusion/prolapse, maternal collapse, or intra-partum 
haemorrhage. It is the association of such events with brain injury (Okereafor et al 2008) and 
the physiologic perturbations in fetal oxygenation and haemodynamics that they reflect that 
provide the rationale for fetal heart rate measurement and electronic fetal monitoring (EFM) 
(Macones et al 2008; Liston et al 2007; Am Col Obs Gyn 2005; Royal College Obs Gyn 2005). 
The purpose of EFM is to provide recognition of ‘non-reassuring’ patterns or frank 
abnormalities in heart rate that leads to prompt obstetric assessment, intervention(s) 
required to relieve compromise to the fetal circulation, or expedited instrumental delivery or 
emergency caesarean section.  
Guidelines for electronic fetal monitoring have been generated in most jurisdictions 
(Macones et al 2008; Liston et al 2007; Am Col Obs Gyn 2005; Royal College Obs Gyn 2005). 
However, EFM became part of clinical practice following retrospective studies comparing its 
use to historical controls where auscultation was performed. And while case-control studies 
have shown correlation of EFM abnormalities with umbilical artery base excess; only 1 of 13 
randomized controlled trials showed a significant decrease in perinatal mortality comparing 
EFM with auscultation; and meta-analysis found an increased incidence of caesarean 
delivery and decreased neonatal seizures but no effect on the incidence of cerebral palsy or 
perinatal death. (Graham et al 2008)  
Placental pathology: the placenta is one of the least well understood organs in the human 
body, yet it is integral to fetal perfusion, gas exchange (oxygenation and carbon dioxide 
excretion), and nutrition, and protection of the fetus from infection. Many common maternal 
conditions interfere with placental function and fetal oxygenation, including hypertension, 
diabetes, and sickle cell anaemia. The fetus is at particular risk of brain injury in conditions 
where the disturbance of placental gas exchange and fetal perfusion becomes acute and 
severe; examples include pre-eclamptic toxaemia (which, if unchecked, also requires 
delivery of the fetus, regardless of the gestation achieved, in order to restore maternal blood 
pressure and coagulation status), and haemorrhage from placenta praevia or abruption 
where bleeding occurs between the placenta and the uterine wall. In one study aimed at 
establishing the antecedent factors and patterns of brain injury in preterm infants with HIE, 
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placental abruption was the commonest identifiable event (Logitharajah et al 2009). Acute 
maternal infection and transplacental passage of inflammatory cytokines expose the fetal 
brain to direct and indirect damage, and the associated risks of preterm delivery where 
premature rupture of membranes and preterm labour occurs. Less acute situations 
predominantly stem from progressive failure of the placenta to function and provide 
nutrition and gas exchange. Growth retardation occurs with progressive slowing of fetal 
somatic and brain growth (intrauterine growth retardation) and increasing risk of acute 
placental insufficiency leading to fetal distress, again with the likelihood of hypoxia and 
ischemia as the predominant mechanism of brain injury. The umbilical cord, which is the 
conduit for blood flow and gas exchange between the placenta and fetus, is also vulnerable; 
compression, prolapse, occlusion, entrapment and tearing occur, each of which has 
recognized adverse consequences for fetal oxygenation and cerebral blood flow. Partial and 
prolonged and acute near total episodes of hypoxic ischaemic stress occur in consequence. 
Overall the incidence of interruption of adequate placental blood flow during labour is 
approximately 3 of every 1000 term deliveries (Perlman 2011)  
Instrumental delivery: A number of situations require delivery assisted by forceps or 
vacuum extraction. In many instances concern over a non-reassuring pattern in the fetal 
heart rate or other evidence suggests fetal distress has developed, or delivery has been 
delayed sufficiently for the mother or fetus to be deemed at risk.  The principal of forceps 
delivery is to place the blades of the instrument on either side of the fetal head so as to 
contain it within the forceps. Gentle traction is then applied to the handles of the forceps in 
order to dilate the cervix and allow the fetal head to progress down the birth canal. Forceps 
are not intended to pull the fetus through the cervix. With mis-application or undue traction 
applied head trauma can occur – this can result in facial injury including facial palsy, skull 
fracture and intracranial bleeding. Vacuum extraction involves attaching a suction cup to 
the baby's head and then gently applying traction to help ease the baby down the birth 
canal. Although permanent sequelae can result with either motor or cognitive damage, 
generally instrumental delivery does not result in permanent brain injury except under 
more extreme circumstances. This is because there are strict guidelines related to both the 
application of forceps and the use of vacuum extraction, all of which are intended to 
optimize delivery and avoid the risk of head trauma and associated brain injury. The 
principal risks with forceps are application when the fetal head is high in the birth canal, 
attempts to rotate the fetal head, or use of excessive force; and with use of the vacuum 
extractor application when the fetus is not sufficiently advanced down the birth canal, or for 
periods that are overly long or repetitive. 
Infants adversely affected often show a degree of neurological depression at birth, and some 
have evidence of skull fractures; there can be associated underlying cortical damage 
(Ferriero 2004), and/or subdural or intracranial bleeding. Cerebellar injury is also described 
(Limperopoulos et al 2009) A small proportion of these brain injured infants then go on to 
develop signs of encephalopathy in the newborn period, but most recover. Occasionally the 
mechanical problems related to the volume of intracranial bleeding require surgical 
drainage. In the premature infant if bleeding occurs that extends into the intraventricular 
compartment this can result in post-haemorrhagic hydrocephalus.  
Breech delivery. The key issues to avoid brain injury in infants presenting by the breech 
(bottom first – or with the part normally covered by the britches presenting) are assistance 
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during delivery to protect the after coming head and the attendance of staff to effectively 
resuscitate the infant, who in many instances is born prematurely and after a degree of 
hypoxic stress. The central problem that predisposes the infant presenting by the breech to 
brain injury is that in the fetus the dimensions of the bottom are smaller than those of the 
head. Hence, after the body of the fetus has passed through the cervix the degree of 
dilatation is insufficient for the after coming head to avoid entrapment. As a result delivery 
is delayed and there is a risk that hypoxic ischemic brain damage will occur.   
The related problem is that when the head is released by the partially dilated cervix an 
abrupt and significant change in intracranial pressure occurs that is associated with a 
comparably large and sudden alteration in cerebral blood volume. In infants who are 
premature in particular this change in pressure and blood volume results in fluctuations in 
cerebral blood flow that are sufficiently extreme for brain ischemia  to be followed by hyper-
perfusion that often results in brain haemorrhage. Superimposed on the period of hypoxia 
and ischemia caused during head entrapment this fluctuation in blood volume is often 
sufficient to cause bleeding into the brain and/or significant brain injury. 
Preventive measures include recognition of breech presentation, and appropriate planning 
to ensure optimal delivery and resuscitation. This may involve operative delivery by 
caesarean section or protection of the after coming head with forceps during delivery, and 
the availability of trained staff to optimally resuscitate a potentially asphyxiated and 
possibly premature infant. In addition, planning is required to ensure safe transport of the 
mother to an appropriate level of care prior to delivery whenever possible, or the 
availability of local staff and/or transport team personnel to resuscitate, care for, and where 
necessary relocate the newborn infant to a facility capable of providing the care he/she 
requires after birth.  
Large for gestational age infants are those weighing more than the 90th centile for their age. 
Such infants are often born to mothers who develop gestational diabetes. Because they are 
large these infants may experience difficult or delayed delivery with the inherent associated 
risks of hypoxic stress. Generally pregnancies compromised by gestational diabetes and 
accelerated fetal growth are electively ended by induction of labour prior to term. This 
reduces the risk of still birth and fetal morbidity from a number of causes. However, the 
principal risk that large gestational age infants face relates to their disordered glucose 
homeostasis that puts them at risk of hypoglycemia in the newborn period. This requires 
careful monitoring of blood glucose and provision of adequate substrate (usually in the 
form of frequent oral or nasogastric tube feeds, or a constant infusion of intravenous 
glucose) sufficient to maintain normoglycaemia. Where seizures occur due to hypoglycemia 
there is a recognized associated morbidity with the brain being vulnerable to injury and the 
risk of abnormal neurodevelopmental outcome. In addition seriously affected infants may 
also have a problems related to cardiac function and the maintenance of an adequate 
circulation due to a pericardial effusion that compromises cardiac output, and hence 
potentially results in impaired cerebral blood flow capable of resulting in brain injury.   
Post mature infants (those born after 42 weeks of gestation) have a number of risks of brain 
injury related to their post maturity; these are mainly still birth or fetal distress due to 
placental failure or obstetric complications during delivery. Rare associations of post 
maturity with of brain anomaly include anencephaly, and bird-headed dwarfism. 
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Multiple pregnancy. The incidence of twins is 11-13 per 1000 pregnancies with a 
predisposition amongst African Americans. Triplet and higher-order multiple births are 
increasing due to IVF. Risks of brain damage exist because of a higher incidence of 
premature delivery and low birth weight, the risks associated with being born second (or 
later) and experiencing hypoxia in consequence, and a higher incidence of cord accidents 
than in singleton births. Congenital brain anomalies occur including anencephaly and 
holoprosencephaly. Vascular shunts between twins and the death of one twin can cause a 
variety of problems; resulting in polycythemia, stroke from emboli, and haemorrhage that 
can cause brain damage. 
Haemorrhage. Major causes of bleeding include placental abruption (separation from the 
uterine wall), placenta praevia, maternal trauma, damage to the umbilical cord, and 
intraventricular haemorrhage. Where haemorrhage involves a significant volume of blood 
loss the fetus loses the ability to maintain adequate levels of oxygen delivery and tissue 
perfusion. While acidosis and hypoxia result brain damage occurs principally because mean 
blood pressure can no longer be maintained, cerebral blood flow falls and hypoxic ischemic 
injury follows. In the preterm infant fluctuations in cerebral perfusion during the evolution 
and management of haemorrhage are often damaging in their own right. Where a maternal 
cause exists, interventions to resuscitate the mother and intervene to address the underlying 
cause of the haemorrhage benefit the infant, provided they are instituted promptly and 
either restore fetal oxygen delivery and perfusion, or deliver the infant allowing extra-
uterine resuscitation. Infants born following a haemorrhagic event need immediate 
assessment at birth of the adequacy of their circulation as part of their resuscitation. Such 
infants not infrequently require prompt intravenous fluid replacement to restore their blood 
volume to adequate levels for normal perfusion and oxygen delivery to occur. Delay in 
delivery of this component of resuscitation can compound the degree of existing hypoxic 
ischemic brain injury. Any pale and neurologically depressed infant needs an assessment of 
the adequacy of blood pressure and circulation in addition to support of respiration, 
oxygenation and cardiac function. 
Hydrops fetalis is a condition where fluid accumulates in the fetus to an extensive degree. 
The majority of cases used to relate to Rhesus disease. Human parvovirus B19 infection 
should be considered in any case of nonimmune hydrops; (De Haan et al 2006) diagnosis is 
mainly through serology and polymerase chain reaction. Surveillance requires sequential 
ultrasound and Doppler screening for signs of fetal anaemia, heart failure and hydrops. 
Intrauterine transfusion in selected cases can be life saving. Cardiac arrhythmia due to supra 
ventricular tachycardia (SVT) can be severe enough in a fetus to cause hydrops, and is 
associated with significant morbidity and mortality. Several reports link SVT with 
neurological morbidity, including periventricular leukomalacia (PVL) and spastic diplegia 
(Oudijk et al 2004).  SVT severe enough to compromise cardiac function and cause hydrops 
reduces brain blood flow sufficiently over time for ischemia and hypoxia to cause brain 
damage. SVT is the most common cause of non-immune hydrops, but it is also the most 
amenable to treatment (Porat et al 2003). Fetal heart rate monitoring is used to diagnose and 
follow fetal arrhythmias.  Diagnosis of hydrops is made by ultrasound when generalized 
skin thickening of greater than 5 mm is present associated with two of the following criteria:  
ascites (fluid in the abdominal cavity), pleural effusion, pericardial effusion or placental 
enlargement (Oudijk et al 2004). 
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If the fetus is mature enough, delivery and post natal treatment is then possible. But if the 
risk from complications of prematurity is too high for safe delivery, therapeutic intervention 
with medication can preserve fetal well-being, as treatment with anti-arrhythmic agents 
ablates the arrhythmia and improves cardiac function. There is evidence that the adverse 
affects of SVT can be tolerated by a fetus for a period of time which makes it probable that 
adequate blood flow to the fetal brain continues initially. But unrecognised and untreated, 
worsening cardiac dysfunction leads to hydrops and compromise of brain blood flow. For 
this reason early diagnosis and interventional management to relieve the adverse effects of 
SVT on the brain are central to ensuring good neurological outcome, particularly in a 
premature infant with an immature brain (Oudijk et al 2004; Porat et al 2003).  
In-vitro fertilization (IVF): Population based studies in Australia, Sweden and the USA 
document that while most children born after IVF are healthy, there are increased rates of 
multiple pregnancy, low birth weight, genetic anomalies, and disability (Hansen et al 2002; 
Schieve et al 2002; Stromberg et al 2002). Infants conceived using IVF are more likely than 
controls to develop neurological disability, impairment or handicap, and especially cerebral 
palsy; this effect is attributed largely but not solely to the high frequency of twins born, and 
to low birth weight and low gestational age, but an effect due to the IVF procedure per se 
cannot be excluded (Stromberg et al 2002). The risk of major birth defects may be as much as 
twice as high as for naturally conceived infants (Hansen et al 2002) and the incidence of low 
birth weight is higher for singletons as well as twins. (Schieve et al 2002)  
Stroke: Strokes can occur in a fetus between 14 weeks of gestation and delivery, and result 
in cerebral palsy, mental retardation and epilepsy. In a review (Ozduman et al 2004) 78% of 
cases of fetal stroke with a reported outcome resulted in either death or adverse 
neurodevelopmental outcome. The principal causes are ischaemic, thrombotic or 
haemorrhagic injuries occurring in utero. Most fetal strokes are of unclear origin, but 
associated maternal conditions recognized to underlie some cases include platelet 
abnormalities, placental pathologies, medication (warfarin and antiepileptic medication 
associated with a decrease in vitamin K dependent coagulation factors), trauma, twin to 
twin transfusion, and Parvovirus B19 infection; fetal factors include cytomegalovirus 
infection and protein C deficiency (Ozduman et al 2004; De Haan et al 2006). Diagnosis in 
utero may be made on routine ultrasound. MRI is the optimal imaging modality. 
4. Cerebral Palsy 
Cerebral Palsy (CP) is the term used for a group of non-progressive disorders of movement 
and posture caused by abnormal development of, or damage to, motor control centers of the 
brain. CP is defined as a static neuromuscular disorder characterized by an abnormal 
control of movement or posture appearing early in life that is not the result of a recognizable 
progressive disease. (Nelson & Ellenberg 1981) CP has a prevalence of approximately 2 per 
1,000 live births and is caused by a variety of congenital and acquired events before, during, 
or after birth. (Phelan et al 2011)  CP has been investigated extensively for epidemiologic 
risk factors with research dating back to the 1970s. (O’Callaghan) A number of key factors 
have been well established to be associated with CP from population-wide databases, and 
with near complete ascertainment and a low likelihood of bias. These include preterm birth, 
low birth weight, infection in pregnancy, and twin births. (O’Callaghan et al 2011) However, 
a large proportion of cases have no identifiable cause, while approximately 10% are 
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estimated to be attributable to asphyxia. (Yudkin et al 1995) Phelan identified the association 
of a sudden and sustained deterioration in fetal heart rate with the criteria developed by the 
task force on neonatal encephalopathy and cerebral palsy for intrapartum asphyxial injury 
in cases where a diagnosis of CP was subsequently made. In a cohort of 7242 children who 
developed CP, 31.3% had had one or more of six defined adverse intrapartum events 
(placental abruption, uterine rupture during labour, fetal distress, birth trauma, umbilical 
cord prolapse, and mild-severe birth asphyxia). (Gilbert et al 2011) Prematurity has the 
greatest impact on the future development of CP, hence the higher incidence of CP in such 
infants. (Gilbert et al 2011) However, birth asphyxia, birth defects and adverse labour events 
contribute significantly as well, suggesting that in preterm infants CP is most likely 
multifactorial (Sukhov et al 2011). There is also data supporting an association between CP 
and maternal infection late in gestation, intrauterine growth restriction, early gestational 
age, multiple birth, family members with cerebral palsy, breech position, smoking and drug 
use, low Apgar scores, male sex, caesarean delivery, and previous miscarriages. 
(O’Callaghan et al 2011)  
By some, “intrauterine infection/inflammation is considered to be the leading identifiable 
risk factor for cerebral palsy” (Bashiri et al 2006) as it so commonly causes neonatal 
complications, including preterm delivery. And while prematurity is a major causal factor in 
CP, the odds of brain injury occurring become much greater in the presence of maternal 
fever, the effects of inflammation, or proven infection than when the only risk factor is 
prematurity. (Gotsch et al 2007; Bashiri et al 2006; Grether & Nelson 1997) 
Criteria (with qualifying definitions) have been developed to define an acute intrapartum 
hypoxic event sufficient to cause cerebral palsy by the Task Force on Neonatal 
Encephalopathy and Cerebral Palsy (American College of Obstetricians and Gynecologists 
2003). The key criteria are summarized in Table 4. 
 
Essential criteria 
(must meet all four) 
 Metabolic acidosis (fetal umbilical cord arterial blood)  
 Encephalopathic state evident in newborn period. 
 Evidence of cerebral palsy at follow up (spastic  
quadriplegia / dyskinesia) 
 Exclusion of other causal mechanisms for CP 
Criteria that 
together suggest 
intrapartum timing, 
but support rather 
than confirm an 
asphyxial cause 
 Sentinel event (immediately before or during labour) 
 Bradycardia (sudden or prolonged), or absent fetal heart rate 
(with persistent, late, or variable decelerations)  
 Apgar score at 5 minutes or beyond of 0–3  
 Multiorgan involvement in the newborn period 
 Early brain imaging showing nonfocal abnormalities 
Table 4. Criteria used to link an acute intrapartum hypoxic event with cerebral palsy 
The abnormalities of muscle control that define CP are often accompanied by other 
neurological and physical abnormalities, and the movement impairments that occur reflect 
the area of brain damaged. Muscle function is variously compromised: they may be 
contracted and tight (spastic); exhibit involuntary writhing movements (athetosis); have 
difficulty with voluntary movement (dyskinesia); and/or exhibit lack of balance and 
coordination with unsteady movements (ataxia).  Monoplegia describes involvement of 
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muscles in one limb; diplegia involvement of both arms or both legs; hemiplegia 
involvement of both limbs on one side of the body; and quadriplegia involvement of all four 
limbs.  CP is categorized first by the type of movement/postural disturbance present, then 
by a description of which limbs are affected, and finally by the severity of motor 
impairment.  These three-part descriptions are helpful in providing a general picture, but 
cannot give a complete description of any one person with CP. The four major classifications 
used to describe CP are: 
 Spastic 
 Athetoid/Dyskinetic 
 Ataxic 
 Mixed  
5. Investigations relevant to causation of brain injury 
Assessment at birth allows the immediate needs of the newborn infant to be provided in 
terms of the resuscitation required to ensure transition from intrauterine to extra uterine life. 
This is a key element in mitigating any residual effects of intrapartum events that have 
damaged the brain or compromised function. It is recognized that the immediate availability 
of skilled personnel able to do this is an important factor in reducing morbidity, especially 
amongst sick and premature newborns, and one of the central responsibilities of those 
providing for their care. In this regard the priorities for resuscitation include establishing 
effective respiration and gas exchange and cardiac output and perfusion, ensuring 
temperature stability to avoid hypothermia, which increases oxygen requirements, and 
addressing any metabolic abnormalities or potential instability. Risks related to any other 
intrapartum causes or aggravating factors in the context of brain function or existing injury 
can also be addressed; examples include the presence or potential for infection to require 
investigation and treatment with prophylactic antibiotics.  
Once the infant is adequately resuscitated, assessment also allows the gestational age of the 
newborn to be assessed, physical growth parameters (height, weight and head 
circumference) to be measured and plotted against standard values, general physical 
examination to be performed to identify any systemic problems, dysmorphic features, or 
congenital anomalies, and full examination of general status of the infant to occur. From the 
standpoint of actual or potentially evolving brain injury, the neurological system is 
examined in detail and the status of the infant documented as a baseline, and as a means of 
planning the next phase of care and appropriate investigations and consultation, and 
beginning the process of considering the ultimate prognosis. Generally an infant born with 
signs of neurological depression, associated with acidosis and low Apgar scores, is 
considered likely to have experienced hypoxia and ischemia during labour; this becomes 
more and more probable where signs of neurological depression and brain dysfunction 
(encephalopathy) evolve in the hours or days that follow birth. 
Umbilical cord blood gas analysis: Levels of fetal oxygenation and acid base status at birth 
can be assessed from cord blood gas measurements taken at birth.  Values differ between 
samples taken from the vein which delivers oxygenated blood to the fetus from the placenta 
and one of the two cord arterial vessels that return blood from the fetus to the placenta. 
Recent significant hypoxic ischemic stress manifests with low oxygen levels and elevated 
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PCO2, and low pH, low bicarbonate and high base deficit levels (elevated acidity). Low pH 
values and high base deficit values in the umbilical arterial sample correlate with an 
increased probability of permanent neurological sequelae following fetal exposure to 
hypoxia and ischemia. The criteria to define an acute intrapartum event as sufficient to 
cause cerebral palsy include a pH <7.00 and base deficit of >12 mmol/L. (Phelan et al 2011) 
The threshold for moderate or severe newborn complications associated with metabolic 
acidosis is an umbilical artery base deficit of >12 mmol/L. (Low et al 1997) Comparison of 
results from reported studies demonstrates a progression of newborn complications with 
increasing severity of metabolic acidosis. The mean value for arterial pH is 7.26 +/- 007 
(Helwig et al 1996), and a pH of <6.8 equates with the probability of neonatal death or major 
neurologic dysfunction (Goodwin et al 1992)  
The range of normal for cord blood gas values in term infants have been reported by Liston 
(Liston et al 2007). The values (mean +/- SD) for umbilical artery samples are: pH = 7.27 +/- 
0.069; PCO2 = 50.3 +/- 11.1 mmHg; HCO3 = 22.0 +/- 3.6 mEq/L; and Base deficit = -2.7 +/- 
2.8 mEq/L. For umbilical vein samples, values are: pH = 7.34 +/- 0.063; PCO2 = 40.7 +/- 7.9 
mmHg; HCO3 = 21.4 +/- 2.5 mEq/L; and Base deficit = -2.4 +/- 2.3 mEq/L.  
Acidosis occurs as a consequence of cellular hypoxia (inadequate oxygenation) and tissue 
ischemia (inadequate blood flow).  Metabolic and respiratory forms are recognized. The test 
used to measure tissue acidity is a blood gas where pH is the principal unit of measurement 
– pH values are on a logarithmic scale so that small differences represent a major change in 
the level of acidosis. Normal cell function only occurs within a narrow range of pH, beyond 
which the ability of cells to maintain normal oxygen and carbon dioxide exchange and 
metabolic and mechanical function is progressively compromised as the degree of acidosis 
increases. The association between acidosis and development of permanent brain injury 
from hypoxic ischemic injury usually occurs in infants who are acidotic and also 
neurologically abnormal at birth, and then develop clear signs of brain dysfunction (HIE) in 
the newborn period. 
Apgar score. Named for Virginia Apgar, this is an objective index used to evaluate the 
condition of a newborn infant based on a rating of 0, 1 or 2 for each of the five components: 
colour, heart rate, response to stimulation of the sole of the foot, muscle tone, and 
respiration. Scores are determined by observing/examining the newborn infant at 1, 5 and 
10 minutes of age. 10 is the maximum (perfect) score.  Babies that have low Apgar scores are 
at increased risk for CP, particularly when low scores persist in spite of resuscitation being 
implemented. Care with interpretation is required where an infant is premature due to an 
associated degree of physical immaturity, and also when scores are estimated after the fact 
as often occurs when active resuscitation is required.  
Ultrasound  (US) studies and neuroradiological scans (Computerized Tomography (CT) 
and/or Magnetic resonance imaging (MRI):  Ultrasound provided the initial method for 
imaging brain structure and is still clinically attractive because of the ability to study sick 
infants in the nursery environment. The development of CT and advent of broadly available 
computer generated images of the brain greatly advanced clinical diagnosis and knowledge 
related to brain development and injury. The outstanding contrast resolution of MRI, 
superimposed on the ability to image in any plane, now allows the identification of even 
subtle brain malformations. (Francis et al 2006) US, CT, and MRI scans are today usually 
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done at defined intervals after birth in order to evaluate the timing and evolution of brain 
injury. Pathology that can be identified includes structural developmental abnormalities, 
oedema (brain swelling), haemorrhage, early ischemic damage, localization of injury to 
cortical tissue or deep brain structures (basal ganglia and thalami), onset and evolution of 
scarring, onset and progression of hydrocephalus or microcephaly. Cerebral oedema 
following hypoxic ischaemic brain injury usually subsides in 48-72 hours, allowing recovery 
of brain stem function; (Perlman & Shah 2011) and intrapartum or late antepartum hypoxic 
ischaemic changes can be distinguished from structural brain damage due to congenital or 
acquired causes that occurred well prior to birth.  
Advanced methods of neuroimaging are the subject of recent reviews; (Glenn & Barkovich 
2006; Mathur et al 2010; Counsell et al 2010; Huang & Castillo 2008) MRI, magnetic 
resonance spectroscopy (MRS), and diffusion-weighted MRI have shown the patterns of 
brain injury that evolve after hypoxic ischaemic insults, that such patterns depend on the 
severity of the insult and the age at which it occurs, and that brain injury evolves over days, 
if not weeks. (Ferriero 2004) The anatomical regions of the brain affected by hypoxic 
ischemic injury define whether the insult occurred acutely and was near total in nature or 
occurred over a more prolonged period and was partial in degree. Deep brain structures 
have a high metabolic rate and hence are injured in acute profound hypoxia as significant 
ischemia develops before compensatory changes in cerebral perfusion can occur. In contrast, 
in partial and prolonged hypoxia, acidosis evolves that leads to preferential perfusion of 
deep brain structures; but ultimately, perfusion of the cerebral cortex is compromised and 
this area of the brain suffers hypoxic ischemic damage.  
Fetal and post-natal MR imaging have redefined the diagnosis of congenital and acquired 
brain injury developing in utero and during the intra-partum period (Glenn & Barkovich 
2006). Fetal MR imaging is a technique that complements prenatal sonography as it has 
higher contrast resolution and allows direct visualization of the fetal brain, and hence more 
readily identifies both cerebral malformations and destructive lesions; including agenesis of 
the corpus callosum, cerebellar dysplasia, germinal matrix haemorrhage, intraventricular 
haemorrhage, multicystic encephalomalacia, periventricular leukomalacia, periventricular 
nodular heterotopias, poroncephaly, and sulcation anomalies (Filey et al 1991; Aubry et al 
2003).  
The most common abnormality observed is enlargement of the ventricles 
(ventriculomegaly), which may result from multiple developmental, obstructive and 
destructive causes; in the majority of cases there are associated anomalies within or beyond 
the central nervous system, which significantly increase the probability of the affected infant 
having developmental delay. Destructive lesions are characterized by periventricular 
hyperintensity, focal defects in the germinal matrix, or areas of abnormal signal intensity in 
the developing white matter. Haemorrhage is usually associated with hypointense areas, 
although signal intensity does vary depending on the stage of evolution. 
For post-natal studies diffusion-weighted MR imaging and proton MR spectroscopy are the 
most sensitive modalities for diagnosis in the early hours following injury and recent 
publications describe the major findings observed (Huang & Castillo 2008).  
Electroencephalogram (EEG) recording monitors the electrical activity of the brain. Seizure 
activity occurring in the brain but not visible clinically may be detected by EEG.   Patterns of 
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brain waves are obtained that allow the location and relative severity of various brain 
pathologies to be identified. Patterns of depression of cortical brain activity on EEG have 
been defined  (Table 2) associated with varying stages and severity of hypoxic ischemic 
encephalopathy (Sarnat and Sarnat 1976). Serial measurements are helpful to document the 
evolution and recovery of abnormal brain function and the effect of therapy. 
Blood counts: The presence of abnormal findings in the white blood cell (WBC) count are 
strongly indicative (although not diagnostic) of the presence of bacterial infection due to 
septicaemia (bacteria multiplying in the blood stream). (Gerdes 2004) Very low counts 
indicate the inability of an infant to mount an effective immune response; elevated numbers 
of total WBC cells, a high proportion of neutrophils (granulocytes), and elevated numbers of 
primitive (band) cells indicate that stimulation of the bone marrow by inflammatory 
cytokines has occurred, and hence such changes evolve over time. Elevation of the band cell 
count is the earliest change seen in the peripheral blood count in response to an 
inflammatory stimulus, which is the most common cause of increased release of primitive 
(band) cells, although hypoxia can also result in an increase in band cell number. 
Measures of haemoglobin concentration or the volume of red blood cells in the circulation 
are used to identify anaemia and polycythemia where too few or too many red cells are 
circulating respectively. Both circumstances compromise oxygen delivery; anaemia by 
limiting the amount of oxygen that can be transported, and polycythemia by reducing the 
ease with which blood flows, which also increases the risk of blood vessel occlusion 
(thrombosis) and is one of the mechanisms underlying stroke. Also, by following serial 
measurements from birth, situations can be identified where bleeding occurred while the 
fetus was in utero. After significant blood loss, the volume of the blood in the circulation is 
reduced, but the haemoglobin concentration remains the same. As physiological 
compensation following haemorrhage occurs, fluid is drawn into the circulation to restore 
blood volume and, as a consequence, haemoglobin concentration and the number of red 
cells per unit of volume (hematocrit) fall. 
Blood chemistry: The full range of biochemical abnormalities associated with brain injury is 
beyond the scope of this chapter. Congenital metabolic abnormalities constitute a small but 
complex group of conditions that require expert assessment, investigation and management. 
Blood glucose, and serum calcium, and electrolyte measurements, in parallel with blood gas 
analysis of pH, oxygen and carbon dioxide tension, bicarbonate and base deficit, are the 
mainstays of clinical monitoring in brain injured infants, particularly when multisystem 
involvement complicates the course of neonatal encephalopathy. Fetal measurement of 
some parameters is feasible; scalp blood sampling in particular has relevance in assessing 
the evolution of hypoxia and acidosis during the later stages of labour via blood gas 
measurement or lactate analysis, once the membranes have ruptured and the fetal head has 
descended into the birth canal. Lactate is a metabolite in aerobic metabolism and reflects 
tissue hypoxia. (Wiberg-Itzel et al 2008) 
6. Prevention of fetal brain injury  
Prevention of fetal brain damage requires knowledge of the aetiologies underlying injury, 
awareness of the availability of preventive measures, and the opportunity to employ them 
to address the underlying cause. In addition, situations that may aggravate existing or 
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evolving brain injury need to be recognized and care provided that is capable of improving 
outcome. Treatment of the effects of fetal brain injury often begins during the newborn 
period and some entities contribute to better outcome. However, the many therapies that 
have to continue during childhood to support infants born with brain damage and those 
that are entailed in providing for their care in adult life are beyond the scope of this chapter.  
Maternal health and diet, parental age, and mode of conception are all relevant. (Hagberg & 
Mallard 2000) The risk of fetal brain injury is decreased where mothers maintain a good 
diet, add appropriate folic acid and iron supplements, and avoid smoking, the detrimental 
effects of alcohol, and exposure to TORCH infections. There are benefits to becoming a 
mother earlier rather than later in life and from lifestyles that promote physical health and 
mental wellness. In vitro-fertilization is associated with an increased risk of multiple 
pregnancy, preterm delivery and some specific structural defects. Good antenatal care is 
central to optimizing the fetal environment, detection of entities that require intervention or 
forward planning, and allowing pregnancy to progress to term.  The fetal brain probably 
benefits most from prevention of avoidable preterm delivery, and therapy such as antenatal 
steroid use to mature the fetal lung (Hagberg & Mallard 2000) when prematurity is 
inevitable. Post maturity with the inherent risks of placental failure and increased fetal 
morbidity must be avoided, especially where at risk situations exist such as gestational 
diabetes. Mothers who have had previous caesarean section require special planning and 
supervision to avoid uterine complications that can jeopardize fetal wellbeing.  
Monitoring during pregnancy should screen for and detect major genetic anomalies, as 
termination of pregnancy is a care option for limiting the incidence of brain injury when a 
fetus is known to have a major anomaly. Confirmation of gestational age by monitoring 
fundal height and using confirmatory ultrasound also reduces the risk of prematurity. And 
allows monitoring of fetal growth parameters to anticipate and manage intrauterine growth 
retardation, and identify placental anomalies that carry a risk of increased morbidity. 
Surveillance for a broad range of maternal illnesses is also possible with preventive entities 
available to optimize fetal growth and health, and select appropriate timing, mode and 
location of labour and delivery.  
Surveillance and monitoring of maternal and fetal wellbeing in labour requires entities that 
provide for anticipation, detection and management of fetal distress. Guidelines exist in 
most jurisdictions based on the evidence base for best practice in obstetric management 
where maternal wellbeing is compromised or the fetus becomes at risk. Where necessary, 
advance consultation with centres specializing in obstetric and newborn care should occur 
for advice regarding ongoing care of the mother and plans for labour and delivery. This may 
require transport of the mother with the fetus still in utero if care at a higher level is 
necessary to optimise the chances of healthy delivery and normal fetal outcome. (Jaimovitch 
& Vidyasagar 1993; Macnab 1994) An important consideration in this regard is that staff are 
available with the required skills to comprehensively resuscitate any sick newborn infant 
and promptly address residual morbidity from premature or complicated delivery; this is 
known to reduce the risks of brain injury following premature delivery, and in situations 
where hypoxia and ischemia or any other form of brain injury is considered a potential risk. 
It also follows that after birth and appropriate resuscitation newborn care entities must be 
available to minimize the risks of any fetal brain injury being compounded or new injury 
occurring in the newborn period. Measures to do this include support of respiration and 
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circulation, provision of a neutral thermal environment, hydration and nutrition, use of 
prophylactic antibiotics and management of proven infections, haematological and 
biochemical monitoring and neuroradiological studies, and appropriate discharge planning 
and follow up.   
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